TY - JOUR
T1 - Differences in demographic and clinical characteristics between cannabis users and non-drug users
T2 - A retrospective study of patients at first hospitalization due to psychotic symptoms
AU - Balan Moshe, Livia
AU - Weizman, Abraham
AU - Ben Dor, David H.
AU - Konas, Shai
AU - Fischel, Zvi
AU - Aizenberg, Dov
AU - Gothelf, Doron
AU - Valevski, Avi
N1 - Publisher Copyright:
© 2018
PY - 2018/10
Y1 - 2018/10
N2 - This retrospective, chart review, cohort study compared demographic and clinical characteristics of cannabis -users and non-drug users at first admission due to psychotic symptoms at Geha Mental Health Center, Israel, between August 2002 and December 2013. We assessed the role of current cannabis use as a risk for re-hospitalization during this period as well as the stability of psychotic diagnoses at re-hospitalization. A total of 318 patients were included in the study, of which 106 (33.3%) were cannabis -users. The cannabis-user group had a shorter duration of hospitalization than the non-drug user group but without a significant difference in 5-year re-hospitalization rates. The latter had a higher rate of severe mental illness (SMI) diagnoses at first hospitalization (53.3% vs. 20.3%, respectively), but the difference disappeared at the second hospitalization. The two groups demonstrated a 79–80% rate of conversion from a non-SMI to an SMI diagnosis between the admissions. The results indicate the instability of non-SMI diagnoses at first hospitalization due to psychotic symptoms, regardless of concurrent cannabis use. The high conversion rate from non-SMI to SMI in current cannabis-users may be due to under-diagnosis of SMI at first admission or an effect of cannabis on the development of SMI.
AB - This retrospective, chart review, cohort study compared demographic and clinical characteristics of cannabis -users and non-drug users at first admission due to psychotic symptoms at Geha Mental Health Center, Israel, between August 2002 and December 2013. We assessed the role of current cannabis use as a risk for re-hospitalization during this period as well as the stability of psychotic diagnoses at re-hospitalization. A total of 318 patients were included in the study, of which 106 (33.3%) were cannabis -users. The cannabis-user group had a shorter duration of hospitalization than the non-drug user group but without a significant difference in 5-year re-hospitalization rates. The latter had a higher rate of severe mental illness (SMI) diagnoses at first hospitalization (53.3% vs. 20.3%, respectively), but the difference disappeared at the second hospitalization. The two groups demonstrated a 79–80% rate of conversion from a non-SMI to an SMI diagnosis between the admissions. The results indicate the instability of non-SMI diagnoses at first hospitalization due to psychotic symptoms, regardless of concurrent cannabis use. The high conversion rate from non-SMI to SMI in current cannabis-users may be due to under-diagnosis of SMI at first admission or an effect of cannabis on the development of SMI.
KW - Cannabis-induced psychosis
KW - First episode psychosis
KW - Re-hospitalization
KW - Schizophrenia
KW - Severe mental illness
KW - Stability of diagnosis
UR - http://www.scopus.com/inward/record.url?scp=85051677117&partnerID=8YFLogxK
U2 - 10.1016/j.psychres.2018.07.037
DO - 10.1016/j.psychres.2018.07.037
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 30130713
AN - SCOPUS:85051677117
SN - 0165-1781
VL - 268
SP - 454
EP - 459
JO - Psychiatry Research
JF - Psychiatry Research
ER -